HOW DOES THE USE OF CONTINUOUS GLUCOSE MONITORING DIFFER AMONG PEOPLE WITH ESKD AFTER KIDNEY TRANSPLANTATION, ON HEMODIALYSIS, AND ON PERITONEAL DIALYSIS?

https://storage.unitedwebnetwork.com/files/1099/b61449ffc3081511324c0415eca415be.pdf
HOW DOES THE USE OF CONTINUOUS GLUCOSE MONITORING DIFFER AMONG PEOPLE WITH ESKD AFTER KIDNEY TRANSPLANTATION, ON HEMODIALYSIS, AND ON PERITONEAL DIALYSIS?
Zuzanna
Jakubowska
Jolanta Malyszko jolanta.malyszko@wum.edu.pl Medical University of Warsaw Department of Nephrology, Dialysis and Internal Medicine Warsaw